The outcome of COVID-19 in patients with hematological malignancy

dc.date.accessioned	2023-03-06T07:33:09Z
dc.date.available	2023-03-06T07:33:09Z
dc.date.issued	2021
dc.identifier.citation	J Med Virol. 2021 Feb;93(2):1099-1104. doi: 10.1002/jmv.26404. Epub 2020 Aug 26.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100553
dc.relation.isversionof	10.1002/jmv.26404
dc.relation.isversionof	10.1002/jmv.26404
dc.title	The outcome of COVID-19 in patients with hematological malignancy
dc.relation.journal	J Med Virol
dc.identifier.doi	10.1002/jmv.26404
dc.contributor.author	Yigenoglu TN
dc.contributor.author	Yigenoglu TN
dc.contributor.author	Ata N
dc.contributor.author	Altuntas F
dc.contributor.author	Bascı S
dc.contributor.author	Dal MS
dc.contributor.author	Korkmaz S
dc.contributor.author	Namdaroglu S